Quantbot Technologies LP Sells 75,666 Shares of Option Care Health, Inc. $OPCH

Quantbot Technologies LP lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 84.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,412 shares of the company’s stock after selling 75,666 shares during the period. Quantbot Technologies LP’s holdings in Option Care Health were worth $400,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in OPCH. Royal Bank of Canada lifted its stake in Option Care Health by 20.7% during the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after purchasing an additional 39,661 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after buying an additional 25,777 shares during the period. Empowered Funds LLC bought a new position in shares of Option Care Health during the first quarter valued at about $208,000. Envestnet Asset Management Inc. raised its position in Option Care Health by 8.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 198,876 shares of the company’s stock valued at $6,459,000 after purchasing an additional 14,696 shares during the last quarter. Finally, Atria Investments Inc lifted its stake in Option Care Health by 45.3% in the second quarter. Atria Investments Inc now owns 10,898 shares of the company’s stock worth $354,000 after acquiring an additional 3,397 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $29.67 on Tuesday. Option Care Health, Inc. has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The firm has a fifty day moving average price of $33.78 and a 200 day moving average price of $30.71. The firm has a market cap of $4.64 billion, a price-to-earnings ratio of 23.18, a P/E/G ratio of 1.67 and a beta of 0.85.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.The firm’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.44 earnings per share. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research analyst reports. Jefferies Financial Group restated a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. Citizens Jmp reissued a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft increased their target price on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Finally, Wall Street Zen lowered Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $37.27.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.